INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Kevin R. Smith CEO | XSTU Exchange | 45780L104 CUSIP |
| US Country | 753 Employees | - Last Dividend | - Last Split | 14 Feb 2014 IPO Date |
Inogen, Inc. is a leading medical technology company that focuses on the development, manufacturing, and commercialization of portable oxygen concentrators. These devices are essential for patients who require supplemental long-term oxygen therapy, catering to those suffering from chronic respiratory conditions. The company's mission is to improve the quality of life for its users by offering innovative solutions that promote mobility and independence. Inogen has established a strong market presence both in the United States and internationally, serving patients, physicians, other clinicians, and third-party payors. Founded in 2001, Inogen has its headquarters in Goleta, California, from where it continues to expand its reach and impact in the medical technology space.